Search Our Site

News tagged with:

"medical"

Unnecessary Medical Care Is More Common Than You Think

A study in Washington state found that in a single year more than 600,000 patients underwent treatment they didn’t need, at an estimated cost of $282 million. “Do no harm” should include the cost of care, too, the report author says. It’s one of the intractable financial boondoggles of the U.S. health care system: Lots... Read More »

Read More →

A study in Washington state found that in a single year more than 600,000 patients underwent treatment they didn’t need, at an estimated cost of $282 million. “Do no harm” should include the cost of care, too, the report author says. It’s one of the intractable financial boondoggles of the U.S. health care system: Lots… Read More »

[...]

Read More

7 Medical Conditions That Will Be Lining Big Pharma’s Pockets by 2020

Imagine a stack of dollar bills reaching from the ground to more than 95,000 miles into the sky — nearly four-tenths of the way to the moon. That stack would total $1.4 trillion. It’s a staggering number. It’s also how much will be spent worldwide on medications by 2020, according to a report from QuintilesIMS. That’s... Read More »

Read More →

Imagine a stack of dollar bills reaching from the ground to more than 95,000 miles into the sky — nearly four-tenths of the way to the moon. That stack would total $1.4 trillion. It’s a staggering number. It’s also how much will be spent worldwide on medications by 2020, according to a report from QuintilesIMS. That’s… Read More »

[...]

Read More

Flimsy evidence behind many FDA approvals

Many drugs granted accelerated approval by the U.S. Food and Drug Administration (FDA) lack clear evidence of safety and effectiveness, and the same is true for most high-risk medical devices, according to two new reports in the Journal of the American Medical Association. The Accelerated Approval pathway makes potentially promising investigational medicines available for use... Read More »

Read More →

Many drugs granted accelerated approval by the U.S. Food and Drug Administration (FDA) lack clear evidence of safety and effectiveness, and the same is true for most high-risk medical devices, according to two new reports in the Journal of the American Medical Association. The Accelerated Approval pathway makes potentially promising investigational medicines available for use… Read More »

[...]

Read More

FDA approves new drug to treat heart failure

The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure. Heart failure is a common condition affecting about 5.1 million people in the United States. It is a condition in which... Read More »

Read More →

The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure. Heart failure is a common condition affecting about 5.1 million people in the United States. It is a condition in which… Read More »

[...]

Read More

FDA approves SAPIEN 3 THV artificial heart valve

Originally posted on: FDA.gov The U.S. Food and Drug Administration today approved the SAPIEN 3 Transcatheter Heart Valve (THV) for patients with a narrowing in the heart’s aortic valve, called aortic valve stenosis. Aortic valve stenosis obstructs blood flow from the heart into the aorta, which can lead to serious heart problems. The SAPIEN 3... Read More »

Read More →

Originally posted on: FDA.gov The U.S. Food and Drug Administration today approved the SAPIEN 3 Transcatheter Heart Valve (THV) for patients with a narrowing in the heart’s aortic valve, called aortic valve stenosis. Aortic valve stenosis obstructs blood flow from the heart into the aorta, which can lead to serious heart problems. The SAPIEN 3… Read More »

[...]

Read More

FDA approves brain implant to help reduce Parkinson’s disease and essential tremor symptoms

Originally posted on: FDA.gov The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremor, a movement disorder that is one of the most common causes of tremors. The Brio Neurostimulation System can help some patients when... Read More »

Read More →

Originally posted on: FDA.gov The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremor, a movement disorder that is one of the most common causes of tremors. The Brio Neurostimulation System can help some patients when… Read More »

[...]

Read More

Originally posted on BMJ.com Abstract Objective To test the equivalence for clinical effectiveness between microdecompression and laminectomy in patients with central lumbar spinal stenosis. Design Multicentre observational study. Setting Prospective data from the Norwegian Registry for Spine Surgery. Participants 885 patients with central stenosis of the lumbar spine who underwent surgery at 34 Norwegian orthopaedic… Read More »

[...]

Read More
Categories
Archives